Pacira BioSciences, Inc. PCRX Finite-Lived Intangible Assets, Accumulated Amortization
Finite-Lived Intangible Assets, Accumulated Amortization at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s finite-lived intangible assets, accumulated amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s finite-lived intangible assets, accumulated amortization?
- Pacira BioSciences, Inc. (PCRX) reported finite-lived intangible assets, accumulated amortization of $270.6M in Q1 2026.
- How has Pacira BioSciences, Inc.'s finite-lived intangible assets, accumulated amortization changed year-over-year?
- Pacira BioSciences, Inc.'s finite-lived intangible assets, accumulated amortization increased by 26.9% year-over-year, from $213.31M to $270.6M.
- What is the long-term trend for Pacira BioSciences, Inc.'s finite-lived intangible assets, accumulated amortization?
- Over 4 years (2021 to 2025), Pacira BioSciences, Inc.'s finite-lived intangible assets, accumulated amortization has grown at a 75.3% compound annual growth rate (CAGR), from $27.12M to $256.27M.